Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-03

Clinical Trial Update: Affect of Duavive on Mood & Anxiety Symptoms [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the effects of Duavive on mood and anxiety symptoms in menopausal women; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duavive (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Menopause, Depression, Anxiety | Phase 1 | Status: RECRUITING